The pathophysiology of the collateral circulation (arteriogenesis)

Journal of Pathology

Volumn 190, Issue 3, 2000, Pages 338-342

  Buschmann, Ivo ^a   Schaper, Wolfgang ^a  

^a MAX PLANCK INSTITUTE FOR HEART AND LUNG RESEARCH   (Germany)

Author keywords

Angiogenesis; Arteries versus capillaries; Collateral artery growth; Monocytes; Pluripotent monocyte precursors; Shear stress

Indexed keywords

ANGIOGENESIS; ATHEROSCLEROSIS; BLOOD VESSEL OCCLUSION; COLLATERAL CIRCULATION; CORONARY ARTERY OBSTRUCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE PERFUSION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; TISSUE BLOOD FLOW;

ANGIOGENESIS INDUCING AGENTS; ARTERIOLES; CHEMOKINES; COLLATERAL CIRCULATION; CORONARY DISEASE; HUMANS; MONOCYTES;

EID: 0034094342     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(200002)190:3<338::AID-PATH594>3.0.CO;2-7     Document Type: Review

References (42)

1. The Tf Website. http://www.chd-taskforce.com [25 May 1998].
2. Hamawy AH, Lee LY, Crystal RG, Rosengart TK. Cardiac angiogenesis and gene therapy: a strategy for myocardial revascularization [Review]. Curr Opin Cardiol 1999; 14: 515-522.
3. Carmeliet PDC. Genetic analysis of blood vessel formation: role of endothelial versus smooth muscle cells. Trends Cardiovasc Med 1997; 7: 271-281.
4. Carmeliet PDC. Vascular development and disorders molecular analysis and pathogenic insights. Kidney Int 1998; 53: 1519-1549.
5. Risau W. Development and differentiation of endothelium. Kidney Int 1998; 54: S3-S6.
6. Risau W. Mechanisms of angiogenesis Nature 1997; 386: 671-674.
7. Yancopoulos GD, Klagsbrun M, Folkman J. Vasculogenesis, angiogenesis and growth factors: ephrins enter the fray at the border. Cell 1998; 93: 661-664.
8. Maemura K, Hsieh CM, Jain MK, et al. Generation of a dominant-negative mutant of endothelial PAS domain protein 1 by deletion of a potent C-terminal transactivation domain. J Biol Chem 1999;274:31565-31570.
9. Marme D. Tumor angiogenesis: molecular facts and therapeutic opportunities [Review]. Chirurgie 1999; 70: 31-35 (in German).
10. Plate KH, Beck H, Danner S, Allegrini PR, Wiessner C. Cell type specific upregulation of vascular endothelial growth factor in an MCA-occlusion model of cerebral infarct. J Neuropathol Exp Neurol 1999; 58: 654-666.
11. Soldi R, Mitola S, Strasly M, Defilippi P, Tarone G, Bussolino F. Role of alpha(v)beta(3) integrin in the activation of vascular endothelial growth factor receptor-2. EMBO J 1999; 18: 882-892.
12. Sunderkötter C, Steinbrink K, Goebeler M, Bhardwaj R, Clemens S. Macrophages and angiogenesis. J Leukoc Biol 1994; 55: 410-422.
13. Donnini S, Machein MR, Plate KH, Weich HA. Expression and localization of placenta growth factor and PIGF receptors in human meningiomas. J Pathol 1999; 189: 66-71.
14. De Placido S, Lauria R, Carlomagno C, et al. The impact of schedule on acute toxicity and dose-intensity of high-dose chemotherapy with epirubicin and cyclophosphamide plus colony stimulating factors in advanced breast cancer. Int J Oncol 1999; 15: 339-346.
15. Kotch LE, Iyer NV, Laughner E, Semenza GL. Defective vascularization of HIF-1 alpha-null embryos is not associated with VEGF deficiency but with mesenchymal cell death. Dev Biol 1999; 209: 254-267.
16. Stone RM, Berg DT, George SL, et al. Granulocyte macrophage colony-stimulating factor after initial chemotherapy for elderly patients with primary acute myelogenous leukemia. Cancer and leukemia group B [see comments]. N Engl J Med 1995; 332: 1671-1677.
17. Zelzer E, Levy Y, Kahana C, Shilo BZ, Rubinstein M, Cohen B. Insulin induces transcription of target genes through the hypoxia-inducible factor Hif-1-alpha/Arnt. EMBO J 1998; 17: 5085-5094.
18. Isner JM, Pieczek A, Sohainfeld R, et al. Clinical evidence of angiogenesis after arterial gene transfer of ph VEGF 165 in patients with ischemic limb. Lancet 1996; 348: 370-374.
19. Feng D, Nagy JA, Pyne K, Hammel I, Dvorak HF, Dvorak AM. Pathways of macromolecular extravasation across microvascular endothelium in response to VPF VEGF and other vasoactivc mediators [Review]. Microcirculation 1999; 6: 23-44.
20. Cooper ME, Vranes D, Youssef S, et al. Increased renal expression of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 in experimental diabetes. Diabetes 1999; 48: 2229-2239.
21. Fulton WFM. The Coronary Arteries. Charles C. Thomas: Springfield, IL, 1965.
22. Longland CJ. The collateral circulation of the limb. Ann R Coll Surg Engl 1953; 13: 161-164.
23. Buschmann I, Schaper W. Arteriogenesis versus angiogenesis. News Physiol Sci 1999; 14: 121-125.
24. Schaper W, Buschmann I. Collateral circulation and diabetes. Circulation 1999; 99: 2224-2226.
25. Schaper W, Schaper J. Collateral Circulation. Kluwer: Dordrecht. 1993.
26. Buschmann I, Hoefer I, Heil M, v. Royen N, Schaper W. Monoclonal antibodies against ICAM-1 inhibit collateral artery formation. JACC 1999; 33: 318-A.
27. Arras M, Ito WD, Scholz D, Winkler B, Schaper JWS. Monocyte activation in angiogenesis and collateral growth in the rabbit hindlimb. J Clin Invest 1997; 101: 40-50.
28. Ito WD, Arras M, Scholz D, Winkler B, Htun P, Schaper W. Angiogenesis but not collateral growth is associated with ischemia after femoral artery occlusion. Am J Physiol 1997; 273: H1255-H1265.
29. Ito WD, Arras M, Winkler B, Scholz D, Schaper J, Schaper W. Monocyte chemotactic protein-1 increases collateral and peripheral conductance after femoral artery occlusion. Circ Res 1997; 80: 829-837.
30. Schaper W, Buschmann I. Collateral circulation and diabetes [Editorial]. Circulation 1999; 99: 2224-2226.
31. Laham RJ, Simons M. Growth factor therapy in ischemic heart disease. Angiogenesis in Health and Disease - Basic Mechanisms and Clinical Applications. 1999; 451-475.
32. Chappell DC, Varner SE, Nerem RM, Medford RM, Alexander RW. Oscillatory shear stress stimulates adhesion molecule expression in cultured human endothelium. Circ Res 1998; 82: 532-539.
33. Khachigian LMI, Resnick N, Gimbrone MA Jr, Collins T. Nuclear factor-kappa B interacts functionally with the platelet-derived growth factor B-chain shear-stress response element in vascular endothelial cells exposed to fluid shear stress. J Clin Invest 1995; 96: 1169-1175.
34. Kitayami J, Mackay C, Ponath PD, Springer TA. The C-C-chemokinc receptor CCR3 participates in stimulation of eosinophil arrest on inflammatory endothelium in shear flow. J Clin Invest 1998; 101: 2017-2024.
35. Kosaki K, Ando J, Korenaga R, Kurokawa T, Kamiya A. Fluid shear stress increases the production of granulocyte macrophage colony-stimulating factor by endothelial cells via mRNA stabilization. Circ Res 1998; 82: 794-802.
36. Nagel T, Resnick N, Atkinson WJ, Dewey CFJ, Gimbrone MAJ. Shear stress selectively upregulates intercellular adhesion molecule-1 expression in cultured human vascular endothelial cells. J Clin Invest 1994; 94: 885-891.
37. Shyy Y-J, Hsieh H-J, Usami S, Chien S. Fluid shear stress induces a biphasic response of human monocyte chemotactic protein 1 expression in vascular endothelium. Proc Natl Acad Sci USA 1994; 91: 4678-4682.
38. Wolf C, Cai WJ, Vosschulte R, et al. Vascular remodeling and altered protein expression during growth of coronary collateral arteries. J Mol Cell Cardiol 1998; 30: 2291-2305.
39. Donahue RE, Wang EA, Stone DK, et al. Stimulation of haematopoiesis in primates by continuous infusion of recombinant human GM-CSF. Nature 1986; 321: 872-875.
40. Chachoua A, Oratz R, Hoogmoed R, et al. Monocyte activation following systemic administration of granulocyte-macrophage colony-stimulating factor. J Immunother Emphasis Tumor Immunol 1994; 15: 217-224.
41. Jones TC. The effects of rhGM-CSF on macrophage function. Eur J Cancer 1993; 29A: S10-S13.
42. Plenz G, Koenig C, Severs NJ, Robenek H. Smooth muscle cells express granulocyte macrophage colony-stimulating factor in the undiseased and atherosclerotic human coronary artery. Arteriosclerosis, Thrombosis Vasc Biol 1997; 17: 2489-2499.